Brian Skorney
Stock Analyst at Robert W. Baird
(0.09)
# 4,742
Out of 5,065 analysts
829
Total ratings
34%
Success rate
-7.3%
Average return
Main Sectors:
Stocks Rated by Brian Skorney
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRIX Nurix Therapeutics | Reiterated: Buy | $26 → $36 | $24.93 | +44.40% | 2 | Oct 13, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Hold | $761 | $782.04 | -2.69% | 65 | Oct 2, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $123 → $130 | $82.24 | +58.07% | 45 | Sep 29, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $97 → $90 | $35.08 | +156.56% | 7 | Sep 18, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $32 → $26 | $15.23 | +70.72% | 3 | Sep 9, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | $25 | $9.73 | +156.94% | 1 | Sep 3, 2026 | |
| ALMS Alumis | Reiterated: Buy | $17 → $27 | $6.34 | +325.87% | 4 | Sep 1, 2026 | |
| RGNX REGENXBIO | Reiterated: Buy | $32 → $29 | $7.15 | +305.59% | 19 | Aug 25, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $400 → $514 | $260.17 | +97.56% | 4 | Aug 7, 2026 | |
| AMGN Amgen | Reiterated: Sell | $215 → $230 | $424.94 | -45.87% | 52 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $252 → $280 | $208.43 | +34.34% | 3 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $186 → $225 | $136.98 | +64.26% | 53 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $320 → $350 | $501.95 | -30.27% | 59 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $36 | $22.82 | +57.76% | 15 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $241 → $246 | $155.81 | +57.88% | 3 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 → $20 | $17.73 | +12.80% | 108 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $108 → $145 | $153.07 | -5.27% | 81 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $255 → $250 | $233.48 | +7.08% | 97 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $52 | $11.35 | n/a | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $8.36 | n/a | 1 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $20 | $11.41 | n/a | 37 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $2.76 | n/a | 5 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $4.23 | n/a | 24 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $30 | $2.25 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $16.08 | n/a | 7 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7.5 | $0.2031 | n/a | 14 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $27.62 | n/a | 16 | Sep 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $20.18 | n/a | 14 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $7.79 | n/a | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $5.79 | n/a | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $39 | $0.911 | n/a | 6 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $85 → $146 | $11.58 | n/a | 5 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $2.05 | n/a | 11 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19.37 → $8.30 | $2.24 | n/a | 4 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $3 | $0.3816 | n/a | 8 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $144 | $49.24 | n/a | 1 | Mar 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $83 → $138 | $370.17 | n/a | 5 | Feb 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $42 | $95.29 | n/a | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $54.67 | n/a | 11 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $13 | $21.10 | n/a | 7 | Jul 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $2.32 | n/a | 3 | Jan 22, 2015 |
Nurix Therapeutics
Oct 13, 2026
Reiterated: Buy
Price Target: $26 → $36
Current: $24.93
Upside: +44.40%
Regeneron Pharmaceuticals
Oct 2, 2026
Reiterated: Hold
Price Target: $761
Current: $782.04
Upside: -2.69%
Mirum Pharmaceuticals
Sep 29, 2026
Reiterated: Buy
Price Target: $123 → $130
Current: $82.24
Upside: +58.07%
Xenon Pharmaceuticals
Sep 18, 2026
Reiterated: Buy
Price Target: $97 → $90
Current: $35.08
Upside: +156.56%
Dyne Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $32 → $26
Current: $15.23
Upside: +70.72%
Climb Bio
Sep 3, 2026
Reiterated: Buy
Price Target: $25
Current: $9.73
Upside: +156.94%
Alumis
Sep 1, 2026
Reiterated: Buy
Price Target: $17 → $27
Current: $6.34
Upside: +325.87%
REGENXBIO
Aug 25, 2026
Reiterated: Buy
Price Target: $32 → $29
Current: $7.15
Upside: +305.59%
Praxis Precision Medicines
Aug 7, 2026
Reiterated: Buy
Price Target: $400 → $514
Current: $260.17
Upside: +97.56%
Amgen
Aug 5, 2026
Reiterated: Sell
Price Target: $215 → $230
Current: $424.94
Upside: -45.87%
Aug 4, 2026
Reiterated: Buy
Price Target: $252 → $280
Current: $208.43
Upside: +34.34%
Jul 31, 2026
Reiterated: Buy
Price Target: $186 → $225
Current: $136.98
Upside: +64.26%
Jul 7, 2026
Reiterated: Sell
Price Target: $320 → $350
Current: $501.95
Upside: -30.27%
May 18, 2026
Reiterated: Buy
Price Target: $38 → $36
Current: $22.82
Upside: +57.76%
May 5, 2026
Reiterated: Buy
Price Target: $241 → $246
Current: $155.81
Upside: +57.88%
Feb 26, 2026
Reiterated: Hold
Price Target: $22 → $20
Current: $17.73
Upside: +12.80%
Feb 11, 2026
Reiterated: Hold
Price Target: $108 → $145
Current: $153.07
Upside: -5.27%
Oct 31, 2025
Reiterated: Buy
Price Target: $255 → $250
Current: $233.48
Upside: +7.08%
Aug 12, 2025
Reiterated: Buy
Price Target: $57 → $52
Current: $11.35
Upside: n/a
Dec 12, 2024
Initiated Coverage: Buy
Price Target: $30
Current: $8.36
Upside: n/a
Nov 26, 2024
Reiterated: Buy
Price Target: $26 → $20
Current: $11.41
Upside: n/a
Nov 20, 2024
Reiterated: Buy
Price Target: $28
Current: $2.76
Upside: n/a
Nov 6, 2024
Reiterated: Hold
Price Target: $4
Current: $4.23
Upside: n/a
Dec 14, 2023
Downgraded: Hold
Price Target: $28 → $30
Current: $2.25
Upside: n/a
Nov 10, 2022
Reiterated: Buy
Price Target: $28
Current: $16.08
Upside: n/a
Nov 10, 2022
Reiterated: Hold
Price Target: $7.5
Current: $0.2031
Upside: n/a
Sep 8, 2022
Reiterated: Hold
Price Target: $6
Current: $27.62
Upside: n/a
Mar 31, 2022
Reiterated: Buy
Price Target: $15
Current: $20.18
Upside: n/a
Aug 12, 2021
Reiterated: Buy
Price Target: $16
Current: $7.79
Upside: n/a
Aug 12, 2021
Initiated Coverage: Buy
Price Target: $34
Current: $5.79
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $39
Current: $0.911
Upside: n/a
Aug 5, 2021
Reiterated: Hold
Price Target: $85 → $146
Current: $11.58
Upside: n/a
May 10, 2021
Reiterated: Hold
Price Target: $6
Current: $2.05
Upside: n/a
Jul 7, 2020
Reiterated: Buy
Price Target: $19.37 → $8.30
Current: $2.24
Upside: n/a
Nov 1, 2018
Reiterated: Buy
Price Target: $7 → $3
Current: $0.3816
Upside: n/a
Mar 27, 2018
Reiterated: Buy
Price Target: $144
Current: $49.24
Upside: n/a
Feb 28, 2018
Reiterated: Hold
Price Target: $83 → $138
Current: $370.17
Upside: n/a
Jan 4, 2018
Reiterated: Buy
Price Target: $32 → $42
Current: $95.29
Upside: n/a
Oct 3, 2017
Reiterated: Buy
Price Target: $115
Current: $54.67
Upside: n/a
Jul 26, 2017
Reiterated: Hold
Price Target: $14 → $13
Current: $21.10
Upside: n/a
Jan 22, 2015
Reiterated: Buy
Price Target: $11
Current: $2.32
Upside: n/a